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Abstract
Obstructive sleep apnea and hypopnea syndrome is characterized by repeated airway collapse during sleep. The li-
terature describes multiple causes of the disease. The main cause is a reduction of the expansion forces of the pharyn-
geal dilator muscles, as in situations of genioglossal muscle dysfunction, and discoordination between the inspiratory 
activity of the muscle and respiratory effort, which play an important role in progression of the disease.
Other described causes are soft tissue disorders, such as macroglossia or tonsillar hypertrophy, and skeletal struc-
tural alterations such as micrognathia and retrognathia. The syndrome is also more frequent in obese people, 
where the accumulation of fat in the neck region produces narrowing of the pharyngeal airway, thereby diminish-
ing the passage of air. 
This review focuses on the pathogenesis, epidemiology, main features and diagnosis of the disease, and on its 
main forms of treatment.
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Concept
Obstructive sleep apnea syndrome (OSAS) is characte-
rized by episodes of partial or complete obstruction of 
the upper airway during sleep, interrupting (apnea) or 
reducing (hypopnea) the flow of air, followed by tran-
sient awakening that leads to the restoration of upper 
airway permeability.
These cycles of apnea/hypopnea are repeated several 
times everyhour, producing fragmented and scantly re-
pairing sleep. 
Within the upper airway, the pharynx, and particularly the 
oropharynx and hypopharynx, is the region where most 
obstructive processes leading to OSAS are found (1).  
OSAS has a negative impact on the health and behavior 
of millions of adolescents throughout the world. It is an 
independent risk factor for many diseases, such as hyper-
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tension, heart failure, heart attack, cardiovascular event-
sand arrhythmias. Unfortunately, it isa common chronic 
disease that greatly conditions the life of the patient (2).
Breathing disorders related with sleep are studied and 
treated in sleep pathology units involving different spe-
cialists. Orthodontists can make an important contribu-
tion to the diagnosis and management of these diseases, 
and have recently also been incorporated to such units.
The contribution of orthodontists to the study and treat-
ment of respiratory disorders associated with sleep fo-
cuses onthree aspects: 
a) Diagnosis of the structural changes often present in 
these diseases. 
b) The treatment of mild to moderate forms usingin-
traoral appliances. 
c) Presurgical orthodontic treatment of patients pro-
grammed for orthognathic surgery (2).
Epidemiology
OSAS is the second disease in order of frequency 
among the different respiratory disorders, surpassed 
only by asthma.
The syndrome can affect any age group, and is estima-
ted to affect 2-4% of the adult population, though it is 
more common in middle aged males. One out of every 5 
adults suffers moderate OSAS, and one out of every 15 
presents moderate to severe OSAS (3).
The syndrome is characterized by tense breathing, de-
creased levels of oxygen in blood, and arousals that dis-
rupt normal sleep (1).
Some cases posea high risk to health, and patients may 
experience excessive sleepiness during the day, head-
aches in theearly morning, impaired concentration, so-
cial problems, and systemic disorders(1,2).
Pathogenesis
Several factors are implicated in the development of 
OSAS (4). The main cause described in the literature 
is a reduction of the expansion forces of the pharyn-
geal dilator muscles, as in situations of genioglossal 
muscle dysfunction, and discoordination between the 
inspiratory activity of the muscle and respiratory ef-
fort (5), which play an important role in progression 
of the disease.
Additional factors are excessive or elongated tissues of 
the soft palate, macroglossia, tonsillar hypertrophy, and 
a redundant pharyngeal mucosa (6).
Pae et al. found tongue shape in patients with OSAS to 
bedifferent from that ofnormal subjects in the supine 
position this being the first study to evaluate tongue 
shape in the supine position. Tongue shape therefore 
may be taken to play an important role in the develop-
ment of OSAS (7).
Altered upper airway anatomy, conditioned by skeletal 
abnormalities as in Pierre Robin syndrome (8), or by 
alterations of the soft tissues of the neck, particularly 
in obese patients, with increased adipose tissue in the 
region of the neck with fat infiltration and edema in the 
soft palate (9), are also implicated in this syndrome.
Although obesity is regarded as a principal risk factor 
in the occurrence of OSAS, it has been shown that the 
neck perimeter is more closely correlated to severity of 
the syndrome than body mass index, though there is 
usually direct proportionality between obesity and neck 
perimeter (9).
 
Main features of OSAS
With regard to the major signs and symptoms of OSAS, 
a distinction can be made between day and night.
-Nocturnal symptoms
The most frequent and characteristic nocturnal symp-
toms of OSAS are snoring and observed apneas, both of 
which reflect the underlying physiopathological events: 
critical narrowing of the upper airway during sleep and 
intermittent airway collapse, usually reported to the 
doctor by the couple of the patient.
Snoring
Snoringis the most common symptom of OSAS (present 
in up to 95% of all patients) (10). However, it is also very 
common in the adult general population, affecting 25-
30% of all women and 40-45% of all men on a regular 
basis (11).
This explains why snoring is of little diagnostic value in 
identifying OSAS (10).
Patients who consult with suspected OSAS tend to have a 
long prior history of snoring that has become increasingly 
intense and irregular over time, often in connection with 
increased body weight, alcohol consumption or muscle 
relaxant drugs, or with menopause in women (12).
Observed apneas
Apneas are a frequent cause of consultation, since they 
often worry the couple of the patient, describing them as 
respiratory pauses that interrupt snoring while the patient 
continues to make efforts to breathe. Observed apneas are 
more predictive of a high apnea/hypopnea index (AHI) 
than either snoring or excessive daytime sleepiness.
Arousals
Arousals or awakenings are less frequent than observed 
apneas. Such situations correspond to “perceived ap-
neas” that endwhen arousal occurs. They are conscious 
phenomena and are accompanied by brief and intense 
dyspnea sensation.
This symptom is related tohigh blood pressure (3), be-
cause repeated arousals are linked to sympathetic dis-
charges that raiseblood pressure and heart rate.
Choking, diaphoresis, nocturia, restless sleep and somnil-
oquy are additional nocturnal symptoms related to OSAS.
-Daytime symptoms
Daytime sleepiness
Sleepiness is the most important daytime symptom of 
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OSAS, and is due to the fragmentation of sleep caused 
by recurrent electroencephalographic awakening that 
usually terminate the apneas and hypopneas (10).
Daytime sleepiness is of scant diagnostic value, because 
a number of situations and disease processes can cause 
the same symptoms (12).
Morning headaches, apathy, depression, concentra-
tion difficulties, memory loss and decreased libido are 
other characteristic daytime symptoms of patients with 
OSAS, all as a consequence of daytime sleepiness.
Diagnosis
An essential requirement for a correct diagnosis of 
OSAS is a correct anamnesis, recording the family his-
tory (history of OSAS) and personal antecedents (ton-
sillectomy/adenoidectomy in childhood, alcohol intake, 
the use of muscle relaxant drugs, obesity, etc). It is also 
important to establish the profession of the patient, 
since in some professions OSAS constitutes a medical 
emergency (12).
A proper physical examination is also required (height, 
weight, body mass index, cardiovascular evaluation), 
including exploration of the upper airway (19) (nasal 
passages, oropharynx and hypopharynx, and larynx).
The above data in turn should be complemented by ra-
diological study in the form of either conventional la-
teral X-rays (13) or a tridimensional X-ray study (14), 
which will reveal the craniofacial anatomical alterations 
predisposing to OSAS (15).
Many tests are available for evaluating sleep and for 
diagnosing OSAS. The most widely used technique 
is polysomnography (PSG) (16), which monitors the 
sleeping state, respiration, electrocardiogram, move-
ments of the legs, oximetry and snoring. In addition, 
PSG records the distribution of the stages of sleep, the 
number of awakenings, the number of apneas or hypop-
neas, the starting time of sleep, and the hours of efficient 
sleep(hours asleep/hours in bed). PSG also provides the 
apnea / hypopnea index (AHI); in this context, apnea 
is very serious and can only be treated surgically when 
AHI >30, while AHI 15-30 defines moderate apnea, and 
an AHI score of < 15 indicates mild apnea.
While PGS provides a lot of information, it is a complex 
and expensive technique – this limiting its practical ap-
plicability to the evaluation and treatment of OSAS. 
For this reason, simple tests have been developed and 
are now used in many healthcare systems. While such 
techniques provide less information, they are cheaper 
and can be applied in the home of the patient (17).
Main treatment options
Regarding the treatment of OSAS, emphasis firstly 
must be placed on the importance of behavioral modifi-
cations on the part of patients with OSAS, including the 
adoption of a regular sleep schedule, ensuring a good 
environment for adequate sleep, not lying down without 
the need to sleep, and the avoidance of too much time 
in bed. Secondly, alcohol consumption and smoking 
should be avoided. In this context, smoking increases 
inflammation of the upper airway and implies a greater 
risk of snoring and OSAS (18). Alcohol consumption 
in turn is associated with exacerbation of the number 
and duration of apneas, arterial desaturation and sleep 
fragmentation (19).
The American Association of Sleep Disorders (20) has 
proposed the use of oral appliances in order to elimi-
nate snoring or sleep apnea, classifying them as follows: 
mandible advancement appliances, lingual retainers, 
appliances that act upon the soft palate, and combined 
advancement and positive pressure appliances.
Mandible advancement appliances are mostly manu-
factured with an advance of 80% of maximum pro-
trusion (21). There are monoblock types and devices 
manufactured with two splints – no differences in 
success rate being observed between the two designs 
(22). According to the literature, the success of these 
appliances is associated with lower AHI scores as es-
tablished by PSG (23).
Regarding the side effects of these appliances, various 
authors have reported pain in the upper and lower inci-
sors, joint discomfort, dental or facial muscle discom-
fort, excessive salivation, dryness of the mouth, head-
ache and bruxism, while other authors have reported 
only minimum dental and orthopedic effects following 
the use of these appliances (24,25). 
Comparison of these appliances with continuous posi-
tive airway pressure (CPAP) shows them to be less ef-
fective in reducing the AHI score (26).
CPAP was introduced by Sullivan in 1981 (27). In this 
form of treatment, the patient wears a mask at night, 
attached to a machine that continuously impels air into 
the airway. This increases the air pressure in the phar-
ynx; air forces the soft palate to move forwards against 
the tongue, and the upper airway thus receives pressure 
and does not collapse. 
This technique requires great effort on the part of the 
patient, but is also the most effective form of treatment, 
as it has been shown to reduce the AHI score to less 
than 5 events per hour in most patients - with improve-
ments in both objective and subjective sleep, and in the 
cardiovascular results (28). However, while very effec-
tive, many patients cannot tolerate CPAP every night 
for life; its acceptance is therefore rather low (28).
When non-surgical techniques for the treatment of 
OSAS fail or are unacceptable to patients, surgery is 
considered. The main options are briefly described in 
the ASDA 1996, and are the following (29).
-Tracheotomy
Tracheotomy was the first surgical technique described 
for the treatment of OSAS. In patients subjected to this 
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technique, the tracheal hole is not kept open through-
out the day, and a plug is used to allow the patient to 
breathe through the nose and mouth. The plug in turn is 
removed at night so that the air penetrates directly into 
the distal portion of the trachea (28).
Uvulopalato-pharyngoplasty (UPPP)
UPPP, initially described by Fujita et al., is used to cor-
rect obstruction atoropharyngeal level by modifying the 
uvula, removing the increased palatal or pharyngeal tis-
sue, and primary closing the posterior and anterior pil-
lars to expand the retropalatine tract (30). 
Kamami was the first to describe laser-assisted 
uvulopalatoplasty(LA-UPP) in the 1980s to reduce the 
uvula and the distal portion of the soft palate without 
total excision of the muscle of the uvula (31).
This technique constituted first choice treatment. How-
ever, it is only able to improve the condition in 50% of 
all OSAS patients. Friedman et al. reported a 41% suc-
cess rate with this technique (32).
-Tonsillectomy
Although rare in adults, hypertrophic tonsils can be an 
important factor in OSAS. In severe cases of obstruc-
tive tonsils, tonsillectomy at any age provides benefits 
and has a positive impact on the obstruction of the upper 
airway (32). Krespi and Ling have described several ton-
sillectomy procedures with the CO2 laser. The tonsillar 
tissue is removed in less time, with less bleeding, and 
with less postoperative pain compared with traditional 
tonsillectomy, though this procedure has been associ-
ated with a higher tonsillar tissue recurrence rate (33).
Radiofrequency ablation of the tonsils is another tech-
nique based on energy transfer through electromagnetic 
radiation to generate heat within the tissues. It is used to 
achieve a reduction in tissue volume followed by heal-
ing, and can be accompanied by similar treatment of the 
base of the tongue. Clinical trials suggest less pain with 
this procedure than with total resective surgery (34).
-Osteotomy of maxillo-mandibular advancement (mma)
This is currently the first choice treatment for OSAS. By 
advancing the mandible, forward repositioning is car-
ried out of muscles such as the anterior digastric muscle, 
the mylohyoid muscle, genioglossal muscle and genio-
hyoid muscle – stretching the tongue forwards and away 
from the pharynx.
Moving the jaw stretches the palatine tissue, which in turn 
exerts traction upon the palatoglossal muscle and increases 
lingual support, favoring pharyngeal patency (35).
The success rate with MMA is 75-100%; the AHI score 
is improved over the long term even in patients who gain 
some weight, and the results remain stable over time (36).
In 2008 Lye et al. reported a high success rate in relation 
to breathing as well as in the quality of life of patients 
subjected to bimaxillary advancement (37).With regard 
to the indications for MMA surgery in these patients, 
the AHI score must be > 15, with low oxygen saturation 
(<90%) and excessive daytime sleepiness. In addition, 
conservative treatments such as weight loss, mandibu-
lar advancement and/or CPAP devices should be found 
to be poorly tolerated or ineffective in these patients in 
order to choose the surgical option of MMA. On the 
other hand, two characteristics must be fulfilled in order 
to indicate MMA:
(a) Firstly, there must be multiple sites of obstruction, or 
blockage must be diffuse and inaccessible.
(b) Secondly, the patient must present skeletal class II 
malocclusion, and MMA surgery must offer multiple 
benefits for the patient(38).
An additional procedure for completing MMA is ge-
nioglossal muscle advancement (GA). This can be done 
with a horizontal osteotomy technique popularized by 
Riley et al., or a lower horizontal geniotomy; the stand-
ard chin osteotomy used in orthognathic surgery. This 
technique expands the magnitude of genioglossal, ge-
niohyoid and digastric muscle replacement(39).
Conley et al. published the case of a patient with OSAS 
subjected to transverse osteogenic distraction of the ma-
xilla combined with maxillo-mandibular advancement – 
followed by significant improvement of the apnea (40).
MMA is therefore an efficient technique for the treat-
ment of OSAS patients, given the results of various 
studies that have examined the airways of patient with 
OSAS subjected to this surgical procedure - revealing 
greater posterior and lateral airway dimensions, with 
minimal complications after the operation(37).
Conclusions
- OSAS is a disease that affects millions of people, and 
is linked to cardiovascular consequences and stroke.
- OSAS can be successfully treated in most cases, fol-
lowing the recommended treatment guidelines.
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